Filing Flows

Filing Flows › Companies › Scientific Industries › Cash flow

Scientific Industries cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$912K in Q2 2026

Operating cash flow−$904K
Capital spending−$8K
Free cash flow−$912K
Cash conversion cycle171 days

Analysis

In Q2 2026, Scientific Industries generated −$904K of operating cash flow and spent $8K on capital projects, leaving free cash flow of −$912K. That is $777K more than in Q2 2025 (−$1.7M).

Operating cash flow was −$904K against net income of −$1.2M. The largest differences: stock-based pay +$162K, payables +$120K, prepaid and other assets −$61K.

Its cash conversion cycle was 171 days (receivables 33 + inventory 188 − payables 50).

Free cash flow

Scientific Industries: free cash flow by quarterScientific Industries: free cash flow by quarter−$872KQ3 2024−$402KQ4 2024−$1.5MQ1 2025−$1.7MQ2 2025−$3.8MQ4 2025−$1.0MQ1 2026−$912KQ2 2026
Operating cash flow less capital spending.
Scientific Industries: operating cash flow against capital spendingScientific Industries: operating cash flow against capital spendingOperating cash flowCapital spending−$868K$4KQ3 2024−$379K$23KQ4 2024−$1.5M$26KQ1 2025−$1.7M$7KQ2 2025−$3.8M$20KQ4 2025−$994K$6KQ1 2026−$904K$8KQ2 2026
Latest (Q2 2026): Operating cash flow −$904K, Capital spending $8K.

Capital allocation, year by year

Scientific Industries: where the cash came from (up) and went (down), by fiscal yearScientific Industries: where the cash came from (up) and went (down), by fiscal yearOperating cash flowShares issuedAsset salesCapital spendingFY2023: Operating cash flow −$6.2MFY2023: Shares issued $6.3MFY2023: Capital spending −$132K$6.3MFY2023FY2024: Operating cash flow −$3.7MFY2024: Shares issued $717KFY2024: Capital spending −$99K$717KFY2024FY2025: Operating cash flow −$8.1MFY2025: Shares issued $2.0MFY2025: Asset sales $7.6MFY2025: Capital spending −$63K$9.7MFY2025
Over these 3 years operating cash flow totalled −$18.0M; the largest uses were operating cash flow ($18.0M) and capital spending ($294K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$4.5M
Debtnone
Net cash$4.5M
Cash runway15 months

Scientific Industries is burning cash: its operations consume cash, a free cash flow of −$3.6M a year at the current rate against $4.5M of cash and investments: a runway of about 15 months before any new financing.

Where the cash came from and went

Scientific Industries: sources (+) and uses (−) of cash, Q2 2026Scientific Industries: sources (+) and uses (−) of cash, Q2 2026Other investing$935KOperating cash flow−$904KNot reconciled−$224KCash drawn (+) / kept (−)$181KExchange rates$20KCapital spending−$8K

From profit to cash

Scientific Industries: net income to operating cash flow, Q2 2026Scientific Industries: net income to operating cash flow, Q2 2026Net income−$1.2MDepreciation & amortization$51KStock-based pay$162KReceivables$18KInventory$15KPayables$120KAccrued liabilities$1KPrepaid and other assets−$61KOperating cash flow−$904K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 20263318850171
Q1 20265119751198
Q4 20254410326121
Q3 20255438770371
Q2 202591565105552
Q1 20258548395473
Q4 20247041450434
Q3 20248975893753

Every quarter

QuarterOperating cash flowCapital spendingShares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$904K−$8K—$181K−$912K
Q1 2026−$994K−$6K—$157K−$1.0M
Q4 2025−$3.8M−$20K−$100$207K−$3.8M
Q2 2025−$1.7M−$7K$1.5M−$421K−$1.7M
Q1 2025−$1.5M−$26K—$118K−$1.5M
Q4 2024−$379K−$23K—−$57K−$402K
Q3 2024−$868K−$4K—−$7K−$872K

Scientific Industries: income statement and cash flow

Scientific Industries, Q2 2026: revenue $1.5M (+36% year over year), operating margin -86.6%. The chart follows the revenue to costs, profit and cash.

Scientific Industries: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.